Real-World Incidence of Bleeding Events in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib +/- Obinutuzumab and Requiring Direct Oral Anticoagulation.

10. August 2026

K Fenchel, E von der Heyde, M Zaiss, T Illmer, M Schulze, S Schroeder, D Kummer, Stefan Jäger, P Marschner.

Oncol Res Treat (2026) 49 (Suppl. 1): 1.